Table 1.

Prostate Cancer Patients Demographic (N = 252)

Variable	Progression		Metastasis		PCa specific Death
	No (N = 115)	Yes (N = 137)	No (N = 192)	Yes (N = 60)	No (N = 216)	Yes (N = 36)
Age	58.8 ± 6.5	60.4 ± 6.4	59.5 ± 6.5	60.3 ± 6.5	59.68 ± 6.4	59.58 ± 7.1
Gleason Score (%)
<7	76 (66.1)	45 (32.8)	107 (55.7)	14 (23.3)	114 (52.8)	7 (19.4)
≥7	39 (33.9)	92 (67.2)	85 (44.3)	46 (76.7)	102 (47.2)	29 (80.6)
TNM Stage (%)
T1b/c	10 (8.7)	3 (2.2)	12 (6.3)	1 (1.7)	13 (6.0)
T2a	32 (27.8)	63 (46.0)	69 (35.9)	26 (43.3)	81 (37.5)	14 (38.9)
T2b	56 (48.7)	58 (42.3)	87 (45.3)	27 (45.0)	96 (44.5)	18 (50.0)
T2c	17 (14.8)	13 (9.5)	24 (12.5)	6 (10.0)	26 (12.0)	4 (11.1)
Organ Confined (%)
Yes	41 (35.7)	19 (13.9)	51 (26.6)	9 (15.0)	54 (25.0)	6 (16.7)
No	74 (64.3)	118 (86.1)	141 (73.4)	51 (85.0)	162 (75.0)	30 (83.3)
Focal Extra-Prostatic Extension (%)
Absent	46 (40.0)	33 (24.1)	66 (34.4)	13 (21.7)	71 (32.9)	8 (22.2)
Present	69 (60.0)	104 (75.9)	126 (65.6)	47 (78.3)	145 (67.1)	28 (77.8)
Non-Focal Extra-Prostatic Extension (%)
Absent	70 (60.9)	45 (32.8)	100 (52.1)	15 (25.0)	106 (49.1)	9 (25.0)
Present	45 (39.1)	92 (67.2)	92 (47.9)	45 (75.0)	110 (50.9)	27 (75.0)
Surgical Margin (%)
Negative	100 (87.0)	75 (54.8)	140 (72.9)	35 (58.3)	158 (73.2)	17 (47.2)
Positive	15 (13.0)	62 (45.2)	52 (24.1)	25 (41.7)	58 (26.8)	19 (52.8)
Seminal Vesicle (%)
Negative	109 (94.8)	108 (78.8)	178 (92.7)	39 (65.0)	193 (89.3)	24 (66.7)
Positive	6 (5.2)	29 (21.2)	14 (7.3)	21 (35.0)	23 (10.7)	12 (33.3)
Lymph Node (%)
Negative	113 (98.3)	117 (85.4)	182 (94.8)	48 (80.0)	204 (94.4)	26 (72.2)
Positive	2 (1.7)	20 (14.6)	10 (5.2)	12 (20.0)	12 (5.6)	10 (27.8)